Back to Search
JOSEPH BOKAR, MD
MD
Hematology & Oncology Physician
NPI: 1881619492Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35-062477(OH)
Research & Publications (6)
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.
PMID 19265494·Thyroid·2009
3-trial
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors.
PMID 19011760·Invest New Drugs·2009
3-trial
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles.
PMID 18470481·Invest New Drugs·2008
3-trial
Induction of sporulation in Saccharomyces cerevisiae leads to the formation of N6-methyladenosine in mRNA: a potential mechanism for the activity of the IME4 gene.
PMID 12384598·Nucleic Acids Res·2002
7-preclinical
SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
PMID 11142383·RNA·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11100 EUCLID AVE
CLEVELAND, OH 44106 - Phone
- (216) 844-8500
Quick Facts
- NPI
- 1881619492
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile